These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28036320)

  • 1. Case Report of Severe Antithrombin Deficiency During Extracorporeal Membrane Oxygenation and Therapeutic Plasma Exchange for Double Lung Transplantation.
    Williams B; Mazzeffi MA; Sanchez PG; Pham SM; Kon Z; Tanaka KA
    A A Case Rep; 2017 Jan; 8(1):11-13. PubMed ID: 28036320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
    Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
    Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange on venovenous extracorporeal membrane oxygenation with bivalirudin anticoagulation.
    Preston TJ; Dalton HJ; Nicol KK; Ferrall BR; Miller JC; Hayes D
    World J Pediatr Congenit Heart Surg; 2015 Jan; 6(1):119-22. PubMed ID: 25548358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.
    Panigada M; Cucino A; Spinelli E; Occhipinti G; Panarello G; Novembrino C; Consonni D; Protti A; Lissoni A; Arcadipane A; Pesenti A; Grasselli G
    Crit Care Med; 2020 Nov; 48(11):1636-1644. PubMed ID: 32947474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous extracorporeal membrane oxygenation and therapeutic plasma exchange procedures are tolerable in both pediatric and adult patients.
    Dyer M; Neal MD; Rollins-Raval MA; Raval JS
    Transfusion; 2014 Apr; 54(4):1158-65. PubMed ID: 24117674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes.
    Piacente C; Martucci G; Miceli V; Pavone G; Papeo A; Occhipinti G; Panarello G; Lorusso R; Tanaka K; Arcadipane A
    Perfusion; 2020 Sep; 35(6):452-464. PubMed ID: 32228213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study.
    Mansour A; Berahou M; Odot J; Pontis A; Parasido A; Reizine F; Launey Y; Garlantézec R; Flecher E; Lecompte T; Nesseler N; Gouin-Thibault I
    Anesthesiology; 2024 Jun; 140(6):1153-1164. PubMed ID: 38271619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.
    Wong TE; Delaney M; Gernsheimer T; Matthews DC; Brogan TV; Mazor R; McMullan DM; Reiner AP; Konkle BA
    Pediatr Crit Care Med; 2015 Mar; 16(3):264-9. PubMed ID: 25581634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation: A Worldwide Survey.
    Protti A; Iapichino GE; Di Nardo M; Panigada M; Gattinoni L
    Anesthesiology; 2020 Mar; 132(3):562-570. PubMed ID: 31764152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.
    Dolch ME; Frey L; Hatz R; Uberfuhr PA; Beiras-Fernandez A; Behr J; Irlbeck M; Lung Transplant Group TM
    Exp Clin Transplant; 2010 Dec; 8(4):329-32. PubMed ID: 21143102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
    Chu DC; Abu-Samra AG; Baird GL; Devers C; Sweeney J; Levy MM; Muratore CS; Ventetuolo CE
    Intensive Care Med; 2015 Feb; 41(2):369-70. PubMed ID: 25465907
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis.
    Iapichino GE; Protti A; Andreis DT; Panigada M; Artoni A; Novembrino C; Pesenti A; Gattinoni L
    ASAIO J; 2019; 65(3):257-263. PubMed ID: 29746315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
    Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
    Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.
    Sorial MN; Greene RA; Zullo AR; Berard-Collins C; Willis S
    Int J Artif Organs; 2020 May; 43(5):315-322. PubMed ID: 31750755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls.
    Garcia JP; Kon ZN; Evans C; Wu Z; Iacono AT; McCormick B; Griffith BP
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):755-61. PubMed ID: 21924145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane therapeutic plasma exchange with and without heparin anticoagulation.
    Brunetta Gavranić B; Bašić-Jukić N; Premužić V; Kes P
    J Clin Apher; 2017 Dec; 32(6):479-485. PubMed ID: 28485027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative therapeutic plasma Exchange and intravenous immune globulin for the treatment of heparin induced thrombocytopenia in a lung transplant recipient.
    Mandernach MW; Nandavaram S; Salame B; Machuca T; Pelaez A
    Transfus Apher Sci; 2019 Aug; 58(4):505-507. PubMed ID: 31387833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
    Zhang R; Dahl AB; Marchant B; Jackups RR; Karnes HE; Shah P; Dynis M; Thibodeaux SR; Despotis GJ
    J Clin Apher; 2020 Jan; 35(1):41-49. PubMed ID: 31713919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.